CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD ris...
Saved in:
| Main Authors: | E. V. Privalova, V. Yu. Kaplunova, N. V. Khabarova, G. A. Shakaryants, Yu. N. Belenkov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2013-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/122 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY
by: E. V. Filippov, et al.
Published: (2016-01-01) -
Analysis of electrotherapy of cardioverter defibrillators implanted for the primary prevention of sudden cardiac death
by: V. K. Lebedeva, et al.
Published: (2019-08-01) -
Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01) -
Biventricular hypertrophic cardiomyopathy with ACTC1 and LDB3 mutations, results of primary prevention of sudden cardiac death: а case report
by: V. N. Larina, et al.
Published: (2025-05-01) -
Return‐to‐play in athletes with transvenous and subcutaneous implantable cardiac defibrillator: A meta‐analysis
by: Rifqi Rizkani Eri, et al.
Published: (2025-08-01)